Author

Kaisla Lahdensuo

University of Helsinki

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Approach:statistical model· 4 Assay:whole-exome sequencing· 3 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Aarno V. PalotieiD· 4 shared Erkki Tapio IsometsäiD· 4 shared Jaana SuvisaariiD· 4 shared Jouko K LönnqvistiD· 4 shared Olli KampmaniD· 4 shared Tuula KieseppäiD· 4 shared Annamari Tuulio‐HenrikssoniD· 3 shared Ari Ahola‐OlliiD· 3 shared

Activity by Year

2022-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersGenetic & Genomic Medicine

Aarno V. PalotieORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Ultra-rare coding variants in schizophrenia risk genes are associated with longitudinal phenotypic differences across psychotic disorders

Anders J. Kämpe, Julia Sealock, Evan Jeffrey Giangrande, Calwing Liao, Emilia Vartiainen, Jaana Suvisaari, Markku Lahteenvuo, Tiina Paunio, Lea Urpa, Olli Kampman, Annamari Tuulio‐Henriksson, Jouko K Lönnqvist, Erkki Tapio Isometsä, Tuula Kieseppä, Kaisla Lahdensuo, , Olli P. H. Pietiläinen

This study identifies ultra-rare damaging variants in schizophrenia risk genes and shows they are associated with earlier hospitalizations, greater childhood adversity, and poorer neuropsychological outcomes across psychotic disorders.

medRxiv · Nov 1, 2026 · PreprintGenetic & Genomic Medicine

The impact of rare protein coding genetic variation on adult cognitive function

Chia‐Yen Chen, Ruoyu Tian, Tian Ge, Max Lam, Gabriela Sánchez-Andrade, Tarjinder Singh, Lea Urpa, Jimmy Z. Liu, Mark Sanderson, Christine Rowley, Holly Ironfield, Terry Fang, Biogen Biobank Team, The SUPER-Finland study, Aija Kyttälä, , Heiko Runz

This study identifies eight genes associated with adult cognitive function through rare coding variants and shows how KDM5B dosage affects cognitive traits in mice and humans.

Nature Genetics · May 25, 2023Peer-reviewedGenetic & Genomic Medicine

Functional characterization of six SLCO1B1 (OATP1B1) variants observed in Finnish individuals with a psychotic disorder

Katja Häkkinen, Wilma Kiander, Heidi Kidron, Markku Lähteenvuo, Lea Urpa, Jonne Lintunen, Kati‐Sisko Vellonen, Seppo O. K. Auriola, Minna Torniainen‐Holm, Kaisla Lahdensuo, Olli Kampman, Erkki Tapio Isometsä, Tuula Kieseppä, Jouko K Lönnqvist, Jaana Suvisaari, , the SUPER-Finland researchers listed in the Acknowledgements

The paper investigates six rare SLCO1B1 variants in Finnish individuals with psychosis, finding one variant causes loss-of-function and reduced OATP1B1 protein expression.

Molecular Pharmaceutics · Feb 13, 2023Peer-reviewedGenetic & Genomic Medicine

Implementation of CYP2D6 copy-number imputation panel and frequency of key pharmacogenetic variants in Finnish individuals with a psychotic disorder

Katja Häkkinen, Johanna I. Kiiski, Markku Lähteenvuo, Tuomas Jukuri, Kimmo Suokas, Jussi Niemi-Pynttäri, Tuula Kieseppä, Teemu Männynsalo, Asko Wegelius, Willehard Haaki, Kaisla Lahdensuo, Risto Kajanne, Mari Anneli Kaunisto, Annamari Tuulio‐Henriksson, Olli Kampman, , Ari Ahola‐Olli

The paper constructs a CYP2D6 copy-number imputation panel and reports pharmacogenetic variant frequencies in Finnish individuals with psychosis, showing high imputation accuracy but limited clinical utility.

The Pharmacogenomics Journal · Feb 23, 2022Peer-reviewedGenetic & Genomic Medicine